CD5 and squamous cell carcinoma: We postulate that CD5 and CD117 should be included in the immunohistochemical panel for squamous cell carcinomas and undifferentiated carcinomas of the major salivary glands with an unusual microscopic features, especially if they resemble thymic carcinomas morphologically.